[PDF] Top 20 Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer.
Has 10000 "Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer." found on our website. Below are the top 20 most common "Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer.".
Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer.
... ABSTRACT: Everolimus combined with exemestane is an important treatment option for patients suffering from estrogen receptor-positive, human epidermal growth factor receptor 2-negative, advanced ... Voir le document complet
14
Safety and efficacy of tibolone in breast cancer patients with vasomotor symptoms : a double-blind, randomised non inferiority tria
... assess breast-cancer risk factors, such as family history or Gail-model score, nor did we provide an accurate histopathological classification of the primary ...Most of our study ... Voir le document complet
17
Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes.
... systemic treatment options are available for advanced breast cancer, including endocrine therapy, chemotherapy, anti-human epidermal growth factor receptor 2 (HER2) therapy, and other targeted ... Voir le document complet
15
SAFE study (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment): 1-year clinical and anatomical results
... chart of included patients and populations analysed: (A) full analysis set (FAS) for safety endpoint: all subjects who underwent treatment or attempted treatment with at least one FRED ... Voir le document complet
7
FOLFIRI(R) and Bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms.
... adjusted in the event of toxic ef- fects (National Cancer Institute Common Terminology Criteria for Adverse Events, NCI–CTCAE, version ...to the following ...cycle. In the ... Voir le document complet
11
Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study
... Quality of life The EORTC QLQ- C30 GHS questionnaire completion rate, based on the number of patients still on treatment at each cycle, was at least 92% for each treatment ... Voir le document complet
11
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer
... for the EMBRACE trial. The key point of our work is that patients classified as responder to the last microtubules inhibiting agents display higher rates of disease control ...reduction ... Voir le document complet
13
Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer
... Management of patients with metastatic urothelial carcin- oma of the bladder following treatment with platinum- based chemotherapy remains a major challenge given the difficulty to ... Voir le document complet
10
Triple-negative breast cancer : treatment challenges and solutions
... At the same meeting, initial data from a Phase I study of an anti-PDL1 monoclonal antibody (MPDL3280A, atezoli- zumab) in metastatic TNBC were also ...occurred in 8% of ...with ... Voir le document complet
15
Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients – Design and baseline data LIBERATE trial”
... 27 In addition, the LIBERATE study may also provide valuable information on overall survival, BMD and HRQL, important issues in this disease-free patient group of which 40% is ... Voir le document complet
9
Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer
... group of 24 breast cancer experts review efficacy and safety data from the recent major trials investigating tamoxifen and the third-generation AIs in ... Voir le document complet
11
Assessment of the Acceptability and Feasibility of Using Mobile Robotic Systems for Patient Evaluation
... have the potential to further reduce in-hospital SARS-CoV-2 transmission and conserve personal protective ...reduce the risk of in-hospital disease transmission and enable ... Voir le document complet
14
Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients
... TNF-α treatment has a favourable efficacy, a decrease in the median dose of glucocorticoids and an acceptable tolerance profile in patients with rhupus with refractive ... Voir le document complet
8
Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
... disease, and age at diagnosis (≤55 years ...haplotypes and completion of a full term pregnancy (ever/never), age at first full term pregnancy (in three categories: nulliparous, ≤24, >24), ... Voir le document complet
9
Efficacy and safety of laparoscopic fundoplication in lung transplant recipients
... peri-operative safety, median hospital stay for fundoplication was ...bleeding and gastric wound without postoperative complications except an increased length of hospital ...stay. The UK ... Voir le document complet
46
Treatment-Induced Cardiotoxicity in Breast Cancer: A Review of the Interest of Practicing a Physical Activity
... for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or ...not. The documents may come from teaching and research institutions in ... Voir le document complet
26
Role of stable free radicals in conjugated antioxidant and cytotoxicity treatment of triple negative breast cancer
... involved in many breast cancers, including triple negative breast cancer ...are breast cancers that do not have receptors for estrogen (ER), progesterone (PR), human epidermal growth ... Voir le document complet
22
Application of 19F magnetic resonance to study the efficacy of fluorine labeled drugs in the three-dimensional cultured breast cancer cells
... cells and HMEC cells (0.5 × 10 5 cells mL −1 ) were seeded in the HFB device (FiberCell Systems ...MD). The HFB is a closed loop system, which comprises of porous hydrophilic hollow ... Voir le document complet
19
Management of the Axilla in the Era of Breast Cancer Heterogeneity
... chemotherapy), and optimal irradiation volumes still need to be clearly ...Residual cancer cells in axillary nodes after neoadjuvant chemo- therapy are a strong risk factor of locoregional ... Voir le document complet
6
Efficacy of a hypnosis-based intervention to improve well-being for prostate and breast cancer patients
... A., and Sela, R. (2011). Referral patterns and psychosocial distress in cancer patients accessing a psycho-oncology counseling ...Differences in Depression. Current Directions in ... Voir le document complet
18
Sujets connexes